O
Oliver Schönborn‑Kellenberger
Publications - 1
Citations - 58
Oliver Schönborn‑Kellenberger is an academic researcher. The author has contributed to research in topics: Reactogenicity & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 9 citations.
Papers
More filters
Journal ArticleDOI
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Peter G. Kremsner,P. Mann,Arne Kroidl,Isabel Leroux-Roels,Christoph Schindler,Julian J. Gabor,Mirjam Schunk,Geert Leroux-Roels,Jacobus J. Bosch,Rolf Fendel,Andrea Kreidenweiss,Thirumalaisamy P. Velavan,Mariola Fotin-Mleczek,Stefan O. Mueller,Gianluca Quintini,Oliver Schönborn‑Kellenberger,Dominik Vahrenhorst,Thomas Verstraeten,Margarida Alves de Mesquita,Lisa Walz,Olaf‑Oliver Wolz,Lidia Oostvogels +21 more
TL;DR: In this article, the authors used the RNActive technology platform (CureVac N.V., Tubingen, Germany) to prepare CVnCoV, a COVID-19 vaccine containing sequence-optimized mRNA coding for a stabilised form of SARS-CoV-2 spike (S) protein encapsulated in lipid nanoparticles (LNP).